{
  "content": "ISRCTN59775011  \nInvestigating the clinical and cost-effectiveness of two different drugs (amiodarone and beta blockers) to treat patients with new-onset atrial fibrillation whilst in the intensive care unit",
  "source": "https://www.isrctn.com/pdf/59775011",
  "chunk_id": "3789b5e7-1618-482f-ae1f-503478412cbb",
  "similarity_score": 0.3214491605758667,
  "query": "cost effectiveness economic analysis amiodarone beta-blockers atrial fibrillation healthcare costs hospitalization reduction",
  "rank": 9,
  "title": "Investigating the clinical and cost-effectiveness of two different drugs (amiodarone and beta blockers) to treat patients with new-onset atrial fibrillation whilst in the intensive care unit",
  "authors": "Lisa Holden, Dhruv Parekh",
  "year": "2023",
  "journal": "Not available",
  "reference": "Holden, L., & Parekh, D. (2023). Investigating the clinical and cost-effectiveness of two different drugs (amiodarone and beta blockers) to treat patients with new-onset atrial fibrillation whilst in the intensive care unit. Birmingham Clinical Trials Unit, University of Birmingham. ISRCTN59775011.",
  "doi": "Not available",
  "chunk_index": 0,
  "total_chunks": 29,
  "retrieved_at": "2025-07-24T21:58:16.915737"
}